Table 1 Clinicopathological characteristics of breast cancer patients
Clinical characteristics | N | % |
|---|---|---|
Age(years), media (range) | 59(36,76) | - |
Smoking history | ||
Yes | 17 | 14.1 |
No | 103 | 85.8 |
CEA level | ||
Positive | 15 | 12.5 |
Negative | 105 | 87.5 |
CA-153 level | ||
Positive | 6 | 5 |
Negative | 114 | 95 |
T stage of breast cancer | ||
T1 | 9 | 7.5 |
T2 | 55 | 45.8 |
T3 | 43 | 36.7 |
T4 | 12 | 10 |
N stage of breast cancer | ||
N0 | 14 | 11.7 |
N1 | 48 | 40 |
N2 | 43 | 35.8 |
N3 | 15 | 12.5 |
Clinical stage of breast cancer | ||
I | 9 | 7.5 |
II | 58 | 48.3 |
III | 33 | 27.5 |
IV | 20 | 16.7 |
Therapy methods | ||
Surgery | 104 | 86.3 |
Surgery + NAC | 81 | 67.5 |
Surgery + RT | 20 | 16.3 |
DFI(months), media (range) | 76.7 (15.5,121) | - |
Hilar and/or mediastinal lymph node metastasis | ||
Positive | 71 | 59.2 |
Negative | 49 | 40.8 |
Axillary lymph node metastasis | ||
Positive | 38 | 31.7 |
Negative | 82 | 68.3 |
Extrapulmonary metastasis | ||
Positive | 46 | 38.3 |
Negative | 74 | 61.7 |